← All stocks

MiNK Therapeutics, Inc.

INKT Net selling
CIK 0001840229 #4632 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$46.62K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$46.62K
8 of 8 sales
Net
−$46.62K
−$46.62K against sales at will

By person

7 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Ryan Barbara
Director
$46.62K (8)
−$46.62K
23,591
$301.95K
Buell Jennifer
Chief Executive Officer
67,966
$869.93K
+272.2%
Corvese Brian
Director
54,770
$701.03K
+200.5%
WIINBERG ULF
Director
51,759
$662.49K
+137.8%
Behner Peter
Director
24,404
$312.36K
Kadlec Robert Peter
Director
19,126
$244.80K
+1,457%
Holcomb John Bradley
Director
4,691
$60.04K

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 3,966,392 to 39,549,975 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Ryan Barbara
4 Jun 2026
Director
Sell
1,000
$12.80
$12.80K
Ryan Barbara
4 Jun 2026
Director
Sell
500
$12.68
$6.34K
Ryan Barbara
10 Mar 2026
Director
Sell
500
$15.30
$7.65K
Ryan Barbara
10 Mar 2026
Director
Sell
500
$15.57
$7.78K
Ryan Barbara
10 Mar 2026
Director
Sell
300
$15.28
$4.58K
Ryan Barbara
9 Mar 2026
Director
Sell
200
$10.17
$2.03K
Ryan Barbara
2 Mar 2026
Director
Sell
100
$10.83
$1.08K
Ryan Barbara
27 Feb 2026
Director
Sell
400
$10.86
$4.34K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 60,711
History held since 20 Oct 2021